Fatty Liver Completed Phase 2 Trials for 3-(cyclohexylamino)propanesulfonic acid (DB02219)
Also known as: Liver fatty / Infiltration fatty liver / Fatty liver metamorphosis / Liver fatty metamorphosis / Metamorphosis fatty liver / Liver fatty degeneration / Degeneration fatty liver / Liver fatty infiltration / Fatty liver infiltration / Steatosis of liver (disorder) / Liver fatty change / Steatosis hepatic / Hepatic steatosis / Steatohepatitis (disorder) / Steatohepatitis
Indication | Status | Phase |
---|---|---|
DBCOND0028942 (Fatty Liver) | Completed | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01147523 | Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease | Treatment |